Dusseldorf, Germany (PRWEB) April 28, 2010
The XCell-Center has released encouraging results from a follow-up study of 140 spinal cord injury patients treated with autologous bone marrow stem cells. Overall, nearly 6o% improved following treatment.
These results are consistent with those presented in October, 2009 and they continue to support the premise that spinal cord injury patients can be treated safely and effectively with autologous stem cell therapy.
Patients with measured ASIA scores saw average improvements of about 10% in ASIA motor score, and approximately 20% in ASIA pin prick and light touch measurements.
The most common improvement, reported by almost 7 out of every 10 patients, was the return of feeling to the hands, feet, arms, legs or trunk. Muscle strength and endurance improved in over 65% of those treated and more than half reported a decrease in muscle spasticity.
“Since treatment, I have regained feeling in my legs. ... My bowels are working easier than before and my hips are becoming more stable. Pain in my left leg is down by half and I have been able to stop taking pain pills. Sometimes there is no pain at all. ... I would recommend this treatment to anyone who is considering it," said Harold Poxleitner, a former logger who was injured over 40 years ago and who underwent treatment in November 2009.
Mr. Poxleitner's full story can be read here: http://www.xcell-center.com/patient-stories/spinal-cord/harold-poxleitner.aspx
40% of those who improved experienced better bladder control and over 30% had better bowel control. About a quarter had better erections and a small number of those regained complete sexual function.
“These laudable results illustrate the significant impact that stem cell therapy has on the lives of most spinal injury patients we treat,” remarked Dr. Hans de Munter, the XCell-Center’s Chief Scientific Officer.
Full spinal cord injury treatment results can be viewed here: http://www.xcell-center.com/treatments/results/spinal-cord-injury.aspx
The treatment begins by collecting a small amount bone marrow from the patient’s hip bone using a thin needle under local anesthesia. The stem cells are then separated from the bone marrow at the XCell-Center’s EU certified cGMP laboratory (current good manufacturing process). Before the cells leave the lab, they are counted and their vitality is confirmed. The last step of the treatment is the minimally invasive implantation procedure, which consists of injecting the stem cells into the patient’s spinal fluid using a spinal needle under local anesthesia.
The cost for spinal cord injury treatment starts at 7,545 Euros.
About the XCell-Center
The XCell-Center operates treatment centers in Cologne and Dusseldorf, Germany. It is the first clinic in Europe to specialize in regenerative medicine using autologous bone marrow stem cell therapy and operates in accordance with German law, European guidelines and ISO 9001. Its specialized medical team of German physicians includes specialists in: neurosurgery, orthopedics, cardiology, radiology, anesthesiology and pharmacology.
The XCell-Center also treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Cerebral Palsy, Autism, Spinal Cord Injuries, Orthopedic diseases, Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson's, Alzheimer's and several eye diseases.
Since its inauguration in 2007, the XCell-Center has treated more than 2,500 patients. For safety data please visit: http://www.xcell-center.com/media/89867/safety%20database%20lp%20febr2010.pdf
For more information on Stem Cell Therapy:
at the Institute for Regenerative Medicine
Am Heerdter Krankenhaus 2
40549 Dusseldorf, Germamy
Phone: 1-866-680-8202 (USA Toll-Free) (+49) 0221-802-5095 (Germany)
Fax: 1-713-583-9322 (USA) (+49) 0221-2921-2550 (Germany)